This report presents a comprehensive overview of the Biobanking market in Europe, which shares the history data information from 2012 to 2016, and forecast from 2017 to 2022.
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Biobanking industry.
This report focuses Global and Europe market, including details as following:
Key Players
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Qiagen N.V. (Germany)
Hamilton Company (U.S.)
Brooks Automation (U.S.)
TTP Labtech Ltd (U.K.)
VWR Corporation (U.S.)
Promega Corporation (U.S.)
Chart Industries (U.S.)
Becton, Dickinson and Company (U.S.)
Merck KGaA (Germany)
Micronic (Netherlands)
LVL Technologies GmbH & Co. KG (Germany)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Biokryo GmbH (Germany)
Biobank AS (Norway)
Biorep Technologies Inc. (U.S.)
Cell & Co Bioservices (France)
RUCDR infinite biologics (U.S.)
Modul-Bio (France)
CSols Ltd (U.K.)
Ziath (U.K.)
LabVantage Solutions Inc. (U.S.)
Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Key Product Type
By Product and Service: Equipment, Consumables, Services, Software.
By Sample: Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids.
Key Applications
Regenerative Medicine
Life Science Research
Clinical Research
This report provides a detailed analysis of the market, including its dynamics, structure, characteristics, main players, growth and demand drivers, etc. As a Detailed Analysis report, it covers all details inside analysis and opinion in Biobanking industry.
This report focuses Global and Europe market, including details as following:
Key Players
Thermo Fisher Scientific Inc. (U.S.)
Tecan Group Ltd. (Switzerland)
Qiagen N.V. (Germany)
Hamilton Company (U.S.)
Brooks Automation (U.S.)
TTP Labtech Ltd (U.K.)
VWR Corporation (U.S.)
Promega Corporation (U.S.)
Chart Industries (U.S.)
Becton, Dickinson and Company (U.S.)
Merck KGaA (Germany)
Micronic (Netherlands)
LVL Technologies GmbH & Co. KG (Germany)
Panasonic Healthcare Holdings Co. Ltd (Japan)
Biokryo GmbH (Germany)
Biobank AS (Norway)
Biorep Technologies Inc. (U.S.)
Cell & Co Bioservices (France)
RUCDR infinite biologics (U.S.)
Modul-Bio (France)
CSols Ltd (U.K.)
Ziath (U.K.)
LabVantage Solutions Inc. (U.S.)
Key Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Key Product Type
By Product and Service: Equipment, Consumables, Services, Software.
By Sample: Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids.
Key Applications
Regenerative Medicine
Life Science Research
Clinical Research
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.